Position in FBLG
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$21,684
-$1,393,930 QoQ
Shares Held
16,428
-94.8% QoQ
Ownership
0.315%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#4
of 14 holders
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in FBLG Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Cascade Financial Partners, LLC holds $47,724 across 2 Biotechnology names. FBLG ranks #2 (45.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PLX |
Protalix BioTherapeutics, Inc.
|
12,000 | $26,040 | |
| 2 | FBLG |
FibroBiologics, Inc.
This page
|
16,428 | $21,684 |
All Filings in FBLG
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $21,684 | 16,428 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,415,614 | 314,581 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $3,255,044 | 298,081 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $3,614,827 | 290,581 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $4,681,458 | 260,081 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $11,304,040 | 282,601 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $18,700,741 | 302,601 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $31,442,489 | 315,055 | Shares | Sole | 2024-07-31 | |
| No filing history on record for this holder in this stock. | ||||||